Horizon 2020 program selects Precision NanoSystems’ NanoAssemblr platform to develop RNA medicines
Precision NanoSystems NanoAssemblrâ„¢ platform has been selected for the controlled manufacture of nanomedicines as part of the multinational B-SMART (Brain-Specific, Modular and Active RNA Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results